You are here

Anti-aging Services Market Size to Reach $35.43 Billion by 2026 | CAGR: 5.3%: Grand View Research, Inc.

SAN FRANCISCO, April 15, 2019 /PRNewswire/ -- The global anti-aging services market size is likely to reach USD 35.43 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.3% during the forecast period. Growing aging population along with increasing life expectancy has created a high demand for anti-aging solutions.

Key suggestions from the report:

  • Based on type, the anti-aging services market has been categorized into microdermabrasion, breast augmentation, liposuction, chemical peel, sclerotherapy, intense pulsed light, Botox, dermal fillers, and others
  • Botox injections are likely to witness the fastest growth over the forecast period from 2019 to 2026
  • Based on demographics, the market has been divided into baby boomers, generation X, and generation Y. Generation X population held the leading position in the market in 2018 in terms of revenue
  • North America dominated the market in 2018 due to widening base of generation Y, who are more concerned about beauty, wellness, and physical appearance
  • Developing countries are attracting international patients by developing state-of-art facilities and are offering good quality anti-aging procedures at lower costs. Such price differences play a significant role in the adoption of elective procedures
  • Allergan, Inc.; Beiersdorf AG; Cynosure; Lumenis; Solta Medical, Inc.; Procter & Gamble; Estee Lauder, Inc.; and Elizabeth Arden are some of the key players in the anti-aging services market.

Read 100 page research report with TOC on "Anti-aging Services Market Size, Share & Trends Analysis Report By Demographics, By Type (Chemical Peel, BOTOX, Microdermabrasion, Breast Augmentation, Liposuction), And Segment Forecasts, 2019 - 2026" at:  https://www.grandviewresearch.com/industry-analysis/anti-aging-market

According to 2017 data revision of the World Population Prospects, the proportion of population aged 60 and over is poised to grow by more than two times by 2050 and by more than three times by 2100, increasing from 962 million in 2017 to 2.1 billion by 2050. Hence, the demand for management of anti-aging products is projected to grow rapidly.

The U.S. FDA has approved dermal fillers manufactured from absorbable or temporary material and indicated the correction of moderate to severe skin folds and wrinkles, while permanent dermal fillers have been approved only for the correction of nasolabial folds and cheek acne scars in population over the age of 21. In addition, FDA approved silicone gel-filled and saline-filled type of breast implants, which have the same silicone outer shell. They vary in shell thickness, size, shape, and shell surface texture.

Grand View Research has segmented the global anti-aging services market based on services, demographics, and region:

  • Anti-aging Services Type Outlook (Revenue, USD Million, 2015 - 2026)a
    • Microdermabrasion
    • Breast Augmentation
    • Liposuction
    • Chemical Peel
    • Sclerotherapy
    • Intense Pulsed Light (IPL)
    • Botox
    • Dermal Fillers
    • Others
  • Anti-aging Services Demographics Outlook (Revenue, USD Million, 2015 - 2026)
    • Baby Boomers
    • Generation X
    • Generation Y
  • Anti-aging Services Regional Outlook (Revenue, USD Million, 2015 - 2026)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Switzerland
      • Netherlands
      • Belgium
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Singapore
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • United Arab Emirates

Find more research reports on global pharmaceuticals industry, by Grand View Research:

  • Combination Drugs Diagnostic Market – Global combination drugs diagnostic market is expected to witness exponential growth over the coming seven years due to greater efficiency attached to combination diagnosis and accelerated approval of drugs by the regulating authority.
  • Glioblastoma Multiforme (GBM) Treatment Market – Global glioblastoma multiforme treatment market is expected to witness significant growth over the forecast period owing to the rising incidence of oncology diseases and rising geriatric population base.
  • Cancer Vaccines Drug Pipeline Market – Global cancer vaccine drug pipeline market is estimated to grow at a CAGR exceeding 27% from 2015 to 2022. Rising vaccines usage combined with other therapies is expected to drive market growth.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter